Fillit, Howard http://orcid.org/0000-0002-3509-6706
Green, Allan
Article History
First Online: 13 January 2021
Competing interests
: H.F. has been a paid or unpaid consultant to Alector, Biogen, Genentech, Lilly, Lundbeck, Merck, Otsuka, Roche and Samus Therapeutics. H.F. also participated in a "Mock Advisory Committee" meeting with Biogen to review the presentation that was proposed to be given at the FDA Advisory Committee meeting discussed here. In the past month, A.G. has been a paid consultant to Samus Therapeutics.